Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors FLUIDDA
- 07 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Aug 2017.
- 07 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 23 Sep 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.